Skip to main content
Premium Trial:

Request an Annual Quote

Mark Walport, Mike Dexter, Todd Golub

Premium

Mark Walport has been appointed as the new director of the UK’s Wellcome Trust. He succeeds Mike Dexter, who retires from the Trust at the end of March following a five-year term as director. Walport is currently head of the division of medicine at Imperial College London, and will begin his new position on June 1.

Ardais of Lexington, Mass., has appointed Todd Golub, director for Cancer Genomics at the Whitehead/ MIT Center for Genome Research, to its scientific advisory board.

Filed under

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.